Related Experiment Video
Updated: Mar 27, 2026

A TNBS-Induced Rodent Model to Study the Pathogenic Role of Mechanical Stress in Crohn's Disease
Published on: March 1, 2022
Multi-system inflammatory syndrome in a child with Crohn's disease- a diagnostic dilemma
Barkha Dhanjani1, Shivangi Tetarbe1, Dhruv Gandhi1
1Department of Pediatric Gastroenterology and Hepatology, Bai Jerbai Wadia Hospital for Children, Acharya Dhonde Marg, Parel, Mumbai, Maharashtra 400012, India.
Insights
Post-COVID multisystem inflammatory syndrome in children (MIS-C) can mimic Crohn's disease (CD) flares. Early recognition and aggressive treatment are crucial for children with overlapping MIS-C and CD, as demonstrated in a recovered 14-year-old patient.
Area of Science:
- Pediatric Gastroenterology
- Pediatric Rheumatology
- Pediatric Infectious Diseases
Background:
- Post-COVID multisystem inflammatory syndrome in children (MIS-C) presents a diagnostic challenge, especially in patients with pre-existing inflammatory conditions like Crohn's disease (CD).
- The overlapping symptoms of CD flares and MIS-C necessitate a high index of clinical suspicion for accurate diagnosis and timely management.
- Underlying conditions can complicate the presentation and treatment of MIS-C.
Abstract:
Post-covid multisystem inflammatory syndrome in children (MIS-C) can cause life-threatening inflammation in children, particularly in those with underlying conditions like Crohn's disease (CD). The overlap of symptoms between CD flares and MIS-C can create diagnostic and therapeutic challenges, necessitating high-level clinical suspicion and aggressive management when both conditions coexist. We present a 14-year-old boy, with a 3-year history of CD, who presented with diarrhea, abdominal pain, and weight loss. Investigations revealed anemia, thrombocytosis, hypoalbuminemia, and elevated inflammatory markers and fecal calprotectin. He was treated with methylprednisolone and methotrexate. On day 25 of admission, he developed altered sensorium, inability to ambulate, and hypoxia. He was found to have left ventricular dysfunction, non-hepatic hyperammonemia and cerebral sinus thrombosis. Work-up revealed a pro-inflammatory state with elevated serum ferritin, interleukin-6, d-dimers and positive anti-Covid IgG, and led to the diagnosis of MIS-C overlapping with CD flare. He was treated with intravenous immunoglobulin and recovered.
More Related Videos
09:44Evaluating Therapeutic Interventions in the SHIP-deficient Mouse Model of Crohn Disease-like Ileitis and Fibrosis
Published on: October 14, 2025
09:11Systematic Scoring Analysis for Intestinal Inflammation in a Murine Dextran Sodium Sulfate-Induced Colitis Model
Published on: February 14, 2021
Related Concept Videos
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Inflammatory Response
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents